What Patrick Swayze's Story Can Help Us Understand About Pancreatic Cancer

What was made public

Patrick Swayze, the actor and dancer known for Dirty Dancing and Ghost, died on September 14, 2009, at the age of 57. The cause was pancreatic cancer.

CNN reported the details his treating oncologist chose to share. Dr. George Fisher of Stanford said publicly in early March 2008 that Swayze had pancreatic cancer. Swayze took part in a clinical trial at Stanford and received an experimental drug. Fisher said the disease had spread beyond the pancreas, and described Swayze living with it for nearly two years as an accomplishment.

Swayze kept working during treatment. Beyond what he and his doctor disclosed, his care was private, and this page does not speculate about it.

Why this cancer is usually found late

The pancreas is a soft organ about six inches long, tucked behind the stomach. It makes digestive enzymes and hormones, including insulin.

NCI is direct about the diagnostic problem. Early pancreatic cancer produces few noticeable symptoms. The symptoms it does produce look like other, far more common conditions, such as pancreatitis or an ulcer. And the pancreas is hidden behind other organs, which makes it hard to see clearly on scans.

The result shows in the numbers. SEER records that only 15% of pancreatic cancers are found while still confined to the pancreas. About 51% have already spread to distant sites by the time they are diagnosed.

The question that shapes everything

Once pancreatic cancer is found, the first question is not what stage it is in the usual sense. It is whether the tumor can be removed completely.

NCI calls this resectability, and it drives the whole plan. Imaging decides it: helical CT, MRI, and endoscopic ultrasound, where a camera on a flexible tube carries an ultrasound probe close to the pancreas from inside the gut.

Tumors sort into resectable, borderline resectable, and unresectable, depending mostly on whether the tumor has wrapped around nearby major blood vessels.

There is no reliable tumor marker to lean on. NCI notes that CA 19-9, the blood test most often used, has low specificity. Most people with pancreatic cancer have a raised level, but a normal level does not rule anything out.

What treatment involves

If the tumor is in the head of the pancreas and can be removed, the operation is usually a Whipple procedure. It removes the head of the pancreas, part of the small intestine, the gallbladder, part of the bile duct, and sometimes part of the stomach, then reconnects what is left. It is one of the largest operations in general surgery.

Tumors in the body or tail are treated with a distal pancreatectomy. Occasionally the whole pancreas has to come out.

Chemotherapy usually follows surgery, sometimes with radiation. For borderline resectable tumors, NCI notes that chemotherapy given before surgery, with or without radiation, is recommended by several consensus guidelines.

When surgery is not possible, treatment aims at controlling the disease and its symptoms. NCI states that palliative care can be considered at any stage, not only at the end. That is worth repeating, because it is widely misunderstood. Our page on cancer staging explains how stage and treatment intent relate.

When to get checked

There is no screening test for pancreatic cancer for people at average risk. What follows is about symptoms and about family history.

See a clinician promptly if you have any of these, especially in combination:

• Yellowing of the skin or the whites of the eyes.
• Pale or clay-colored stools, or dark urine.
• Pain in the upper or middle abdomen that goes through to the back.
• Weight loss you did not intend.
• Loss of appetite or persistent fatigue with no clear cause.

Jaundice with pale stools and dark urine is the combination that should prompt a same-week appointment.

NCI lists the main risk factors as family history of pancreatic cancer, cigarette smoking, obesity, chronic pancreatitis, and certain inherited conditions involving the BRCA1, BRCA2, PALB2 and ATM genes. If pancreatic cancer has appeared in more than one close relative, ask about genetic counseling. Surveillance programs exist for some high-risk families, though not for the general population.

The survival picture, honestly stated

The American Cancer Society projects about 67,530 new pancreatic cancer diagnoses in the United States in 2026, and about 52,740 deaths; those are the calendar-year estimates SEER carries. SEER's own measurements put five-year relative survival across all stages at 13.7% for 2016 to 2022, and the median age at diagnosis at 71.

That figure is low, and there is no useful way to soften it. It is also a group average across everyone diagnosed over a span of years, weighted heavily by the majority whose cancer was already advanced. It does not describe the smaller group whose tumor was resectable, and it does not describe any individual.

Statistics of this kind lag behind current treatment by definition. They are a description of the past, not a forecast.

What this does not mean

• One person's course, however public, predicts nothing about anyone else's.
• Living with advanced pancreatic cancer for nearly two years is uncommon. It is not a benchmark.
• Taking part in a clinical trial is not the same as receiving a proven treatment, and trials have their own risks.
• No one can assign a cause in an individual case, and this page does not attempt to.
• A CT scan is not a screening test for pancreatic cancer in people without symptoms or high risk.

The part of a diagnosis that gets least attention is the emotional weight of it, for the person and for everyone around them. Our page on emotions and cancer is a starting point for that.

Sources

• Swayze's 2 years with pancreatic cancer 'an accomplishment' (CNN, September 2009)
• NCI PDQ: Pancreatic Cancer Treatment (Health Professional Version)
• SEER Cancer Stat Facts: Pancreatic Cancer

How this page was made

An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.

Cancer Explained is published by the National Cancer Information Foundation. It is not medical advice and does not suggest a test or treatment.

See an error, old source, or unclear wording? Tell us.